Acon's test is the second coronavirus test to get marketing authorization using the agency's traditional premarket review pathway and the first indicated for use in children under 18, the health regulator said. The FDA had granted emergency-use authorization for the test in 2021 to make it available to consumers without a prescription. In a study reviewed by the FDA, the test correctly identified 89.8% of positive and 99.3% of negative samples in individuals with signs and symptoms of upper respiratory infection.
Biosensors Market is Booming Worldwide with CAGR of 8 2% einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.
Discover the Latest Market Trends and Insights on Point-of-Care Diagnostics Market 2023!! Market Outlook & Competitive Analysis Coherent Market Insights